Delivering on the promise of precision cancer medicine.
作者信息
Berger Michael F, Van Allen Eliezer M
机构信息
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
出版信息
Genome Med. 2016 Oct 25;8(1):110. doi: 10.1186/s13073-016-0373-1.
Abstract
摘要
相似文献
1
Delivering on the promise of precision cancer medicine.兑现精准癌症医学的承诺。
Genome Med. 2016 Oct 25;8(1):110. doi: 10.1186/s13073-016-0373-1.
2
Personalized Medicine: Genomics Trials in Oncology.个性化医疗：肿瘤学中的基因组学试验
Trans Am Clin Climatol Assoc. 2015;126:133-43.
3
Precision medicine beyond medical oncology: using molecular analysis to guide treatments of colorectal neoplasia.肿瘤内科之外的精准医学：利用分子分析指导结直肠肿瘤的治疗
Expert Rev Gastroenterol Hepatol. 2018 Dec;12(12):1179-1181. doi: 10.1080/17474124.2018.1535897. Epub 2018 Oct 17.
4
New ESMO scale ranks mutations as cancer medicine targets.新的欧洲肿瘤内科学会（ESMO）量表将突变列为癌症药物靶点。
Lancet Oncol. 2018 Oct;19(10):e513. doi: 10.1016/S1470-2045(18)30664-8. Epub 2018 Aug 31.
5
Next-Generation Sequencing in Oncology in the Era of Precision Medicine.精准医学时代肿瘤学中的下一代测序
JAMA Oncol. 2016 Jan;2(1):13-4. doi: 10.1001/jamaoncol.2015.4503.
6
Paul Workman: Drugging the Cancer Genome.保罗·沃克曼：对癌症基因组进行药物治疗。
Trends Cancer. 2016 Oct;2(10):544-548. doi: 10.1016/j.trecan.2016.10.004.
7
Giving Up on Precision Oncology? Not So Fast!放弃精准肿瘤学？没那么快！
Clin Transl Sci. 2017 May;10(3):128-129. doi: 10.1111/cts.12457. Epub 2017 Feb 21.
8
Precision oncology: an overview.精准肿瘤学：概述
J Clin Oncol. 2013 May 20;31(15):1803-5. doi: 10.1200/JCO.2013.49.4799. Epub 2013 Apr 15.
9
Precision medicine in pediatric oncology.儿科肿瘤精准医学。
Curr Opin Pediatr. 2018 Feb;30(1):17-24. doi: 10.1097/MOP.0000000000000570.
10
National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network.美国国立癌症研究所针对新的国家临床试验网络的精准医学计划。
Am Soc Clin Oncol Educ Book. 2014:71-6. doi: 10.14694/EdBook_AM.2014.34.71.
引用本文的文献
1
A Systematic Approach to Optimize the Implementation of Precision Oncology in Clinical Practice: A Meeting Proceeding.优化精准肿瘤学在临床实践中实施的系统方法：会议纪要
J Immunother Precis Oncol. 2024 Aug 19;7(3):210-216. doi: 10.36401/JIPO-23-41. eCollection 2024 Aug.
2
Hallmarks of cancer resistance.癌症耐药性的特征。
iScience. 2024 May 15;27(6):109979. doi: 10.1016/j.isci.2024.109979. eCollection 2024 Jun 21.
3
Bioinformatics analyses of combined databases identify shared differentially expressed genes in cancer and autoimmune disease.联合数据库的生物信息学分析鉴定出癌症和自身免疫性疾病中共同差异表达的基因。
J Transl Med. 2023 Feb 10;21(1):109. doi: 10.1186/s12967-023-03943-9.
4
Great future or greedy venture: Precision medicine needs philosophy.伟大的未来还是贪婪的冒险：精准医学需要哲学。
Health Sci Rep. 2021 Sep 14;4(3):e376. doi: 10.1002/hsr2.376. eCollection 2021 Sep.
5
Applying Precision Oncology Principles in Radiation Oncology.将精准肿瘤学原则应用于放射肿瘤学。
JCO Precis Oncol. 2018 May 14;2. doi: 10.1200/PO.18.00034. eCollection 2018.
6
Assessing the Training and Research Environment for Genomics, Bioinformatics, and Immunology in Radiation Oncology.评估放射肿瘤学中基因组学、生物信息学和免疫学的培训与研究环境。
JCO Clin Cancer Inform. 2018 Dec;2:1-9. doi: 10.1200/CCI.18.00045.
7
Breakthroughs in modern cancer therapy and elusive cardiotoxicity: Critical research-practice gaps, challenges, and insights.现代癌症治疗的突破与难以捉摸的心脏毒性：关键的研究与实践差距、挑战及见解
Med Res Rev. 2018 Jan;38(1):325-376. doi: 10.1002/med.21463. Epub 2017 Sep 1.
本文引用的文献
1
The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine.肿瘤分析方法和基因组数据策略对癌症精准医学的影响。
Genome Med. 2016 Jul 26;8(1):79. doi: 10.1186/s13073-016-0333-9.
2
Oncologists' and cancer patients' views on whole-exome sequencing and incidental findings: results from the CanSeq study.肿瘤学家和癌症患者对全外显子组测序及偶然发现的看法：CanSeq研究结果
Genet Med. 2016 Oct;18(10):1011-9. doi: 10.1038/gim.2015.207. Epub 2016 Feb 11.
3
Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth.青少年难治性或复发性癌症管理中的综合临床测序
JAMA. 2015 Sep 1;314(9):913-25. doi: 10.1001/jama.2015.10080.
4
Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations.维莫非尼用于治疗伴有BRAF V600突变的多种非黑色素瘤癌症。
N Engl J Med. 2015 Aug 20;373(8):726-36. doi: 10.1056/NEJMoa1502309.
5
CSER and eMERGE: current and potential state of the display of genetic information in the electronic health record.CSER与eMERGE：电子健康记录中遗传信息显示的现状与潜在状况
J Am Med Inform Assoc. 2015 Nov;22(6):1231-42. doi: 10.1093/jamia/ocv065. Epub 2015 Jul 3.
6
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.错配修复缺陷肿瘤中的程序性死亡受体-1阻断
N Engl J Med. 2015 Jun 25;372(26):2509-20. doi: 10.1056/NEJMoa1500596. Epub 2015 May 30.
7
Integrative clinical genomics of advanced prostate cancer.晚期前列腺癌的整合临床基因组学
Cell. 2015 May 21;161(5):1215-1228. doi: 10.1016/j.cell.2015.05.001.
8
Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology.纪念斯隆凯特琳癌症中心可操作癌症靶点综合突变分析（MSK-IMPACT）：一种基于杂交捕获的实体瘤分子肿瘤学新一代测序临床检测方法。
J Mol Diagn. 2015 May;17(3):251-64. doi: 10.1016/j.jmoldx.2014.12.006. Epub 2015 Mar 20.
9
Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine.全外显子组测序与福尔马林固定石蜡包埋肿瘤样本的临床解读在精准肿瘤医学中的应用
Nat Med. 2014 Jun;20(6):682-8. doi: 10.1038/nm.3559. Epub 2014 May 18.
10
Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.克唑替尼与化疗用于治疗晚期 ALK 阳性肺癌。
N Engl J Med. 2013 Jun 20;368(25):2385-94. doi: 10.1056/NEJMoa1214886. Epub 2013 Jun 1.
Zotero 插件